Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
859K
-
Shares change
-
+815K
-
Total reported value, excl. options
-
$1.08M
-
Value change
-
+$1.03M
-
Number of buys
-
8
-
Number of sells
-
-1
-
Price
-
$1.26
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2016
11 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2016.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 859K shares
of 112M outstanding shares and own 0.77% of the company stock.
Largest 10 shareholders include Sio Capital Management, LLC (554K shares), VANGUARD GROUP INC (206K shares), GEODE CAPITAL MANAGEMENT, LLC (31.3K shares), A.R.T. Advisors, LLC (20.3K shares), NORTHERN TRUST CORP (17K shares), CITADEL ADVISORS LLC (16.6K shares), WELLS FARGO & COMPANY/MN (6.25K shares), UBS Group AG (3.25K shares), Acrospire Investment Management LLC (2.3K shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.81K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.